Knowledge and perception of microbicides among healthcare providers in Calabar, Nigeria by Etokidem, AJ et al.
Background
The first diagnosis of  HIV was reported in the United 
States of  America by the Centers for Disease Control 
among gays on June 5, 19811. Since then, the infection 
has spread to all parts of  the world and has eventually 
become a pandemic. By the end of  2007, UNAIDS 
reported that 46% (15.4 million) of  people living with 
HIV/AIDS worldwide were women2. 
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In sub-Saharan Africa, almost 60 per cent of  adults 
living with HIV/AIDS in 2007 were women3. Every 
day, nearly 7,500 people become infected with HIV 
and 5,500 die from AIDS, mostly due to lack of  HIV 
prevention and treatment services2. 
In Nigeria, the first officially reported diagnosis of  HIV 
was made in a 13-year old female hawker from Benue 
state in 1986. Since then, HIV prevalence in the country 
has increased from 1.8 % in 1991 to 3.8% in 1993, 4.5% 
in 1995, 5.4% in 1999 and 5.8 % in 20014. Although 
the prevalence declined to 5.0% in 2003, 4.4% in 2005, 
4.6% in 2008 and 4.1% in 2010, Nigeria currently has 
the third highest number of  People Living with HIV/
AIDS in the world, after South Africa and India4,5,6.
Aware that prevention is better and cheaper than cure, 
mankind has tried several prevention options since the 
onset of  the pandemic namely, abstinence, condom 
use, being faithful to one uninfected, faithful partner, 
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Background: With the worldwide spread of  HIV/AIDS, the absence of  a known cure and the challenges associated with 
existing prevention methodologies, there is need for new prevention technologies. The successful uptake of  healthcare 
products and services depend, to a large extent, on healthcare providers’ knowledge, perception and attitude regarding 
them. 
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version 3.5.1 
Results: One hundred and sixty-four (46.9%) respondents were medical doctors while 157 (44.9%) were nurses, 7 (2%) were 
Pharmacists and 22 (6.2%) belonged to “other” categories. Thirty- two percent knew the advantages of  microbicides over 
condoms. Sixty-eight percent indicated that microbicides would benefit only women while to 27%, it would benefit both men 
and women. Seventy-five percent of  respondents would be willing to act as community advocates for microbicides while 21% 
would not be willing and 4% were not decided. There was a statistically significant association between professional group 
and willingness to act as community advocates for microbicides. Medical doctors were more likely to act as advocates than 
other professional groups (p<0.05). Female respondents were more likely to have correct knowledge regarding microbicides 
than males (p<0.05)
Conclusion: There are gaps in knowledge regarding microbicides among the health care providers.  Capacity building would 
be successful since the majority are willing to act as community advocates.
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amongst others. Most of  these  prevention options are 
not feasible for millions of  people around the world, 
especially women, who are the most infected  and worst 
affected by the HIV/AIDS pandemic. It has been 
demonstrated that women do not have the social and 
or economic power necessary to insist on condom use 
and fidelity or to abandon partnerships that put them at 
risk7. All these problems led to the search for an HIV 
prevention method that would be under the control 
of  women, which have been named New Prevention 
Technologies (NPTs).  Two of  such technologies, HIV 
vaccines and microbicides, are currently undergoing 
trials and will very likely be available for widespread 
use in the next few years. None of  these new methods 
require a partner’s cooperation. They would put the 
power to protect into women’s hands8,9.
The term microbicides refers to a new type of  product 
being developed that people could use vaginally or 
rectally to protect themselves from HIV and possibly 
other sexually transmitted infections. A microbicide 
could be produced in many forms, including gels, 
creams, suppositories, films, sponge or ring that releases 
the active ingredient over time. Microbicides would be 
the most important innovation in reproductive health 
since the advent of  the pill9.
A study in South Africa demonstrated the need for 
research and awareness creation about microbicides 
among health care providers prior to making the 
product available. This is because health care providers 
have a critical role in informing clients about these new 
HIV prevention measures10.
Introduction
The worst affected of  the over 30 million people living 
with HIV /AIDS worldwide are women2,3. With the 
absence of  any known cure, the failure of  current 
preventive measures and an epileptic anti-retroviral drug 
supply, especially in developing countries where they 
are mostly needed, there is need for newer prevention 
strategies. Such strategies should be more affordable 
and within the control of  the most affected segment of  
the population9,10. Microbicides, a new class of  product 
meant for topical use, have the potential of  meeting this 
need11.
Although there are presently no microbicides available 
for widespread use, most of  the candidate microbicides 
being at various stages of  trial, there is need for research 
and awareness creation about this preventive measure. 
This is because historically, there is always a time lapse 
between when new drugs and health technologies 
have are designed and developed for industrialized 
markets and when they are introduced into developing 
countries, usually several years later, if  at all9.  There is 
therefore need to start the  groundwork now to ensure 
that microbicides, once developed, can quickly become 
available to women in developing countries7,9. 
To ensure such access and prepare for the introduction of  
such technologies, there is need to determine how much 
health care providers know about these technologies 
with a view to filling any identified knowledge gap 
through capacity building and advocacy.
Such research and awareness is also necessary among 
health care providers because not only are they the 
primary source of  reproductive health information for 
potential users both in the public and private health 
institutions, their perception of  microbicides will 
also influence their clients’ perception regarding this 
preventive method. More so, health care providers 
could play a critical role in the success of  microbicide 
research and trials, by providing manpower and technical 
direction. 
Although some studies on the knowledge of  health care 
providers regarding microbicides have been conducted 
in other countries10,11,12, there is a dearth of  such studies 
in Nigeria. This study therefore seeks to contribute 
towards filling this gap.
General objective of  the study
The general objective of  this study was to determine 
the knowledge and perception of  health care providers 
regarding microbicides.
Specific objectives
The specific objectives of  this study were:
To determine the knowledge of  health care providers in 
Calabar regarding microbicides
To determine the perception of  health care providers in 
Calabar regarding microbicides
Materials and methods
A semi-structured self- administered questionnaire was 
administered on 400 randomly selected health care 
providers in Calabar, Cross River State of  Nigeria. A 
list of  private health care facilities and another list of  
public health care facilities were compiled.  Two public 
hospitals (one secondary and one tertiary) and six private 
clinics were randomly selected. In the facilities, using 
the duty roster, systematic random sampling was used 
to select health care providers to participate in the study. 
Data collection was done by 5 trained data collectors in 
2011. The questionnaire sought information regarding 
their socio-demographic characteristics, knowledge and 
perception regarding microbicides, willingness to act as 
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community advocates. Three hundred and fifty (350) 
questionnaire were returned. Data obtained from the 
respondents were analysed using EPI –Info software 
version 3.5.1. Results were presented as tables. Ethical 
approval for the study was obtained from the Research 
Ethics Committee of  the University of  Calabar Teaching 
Hospital, Calabar.
Results
Majority of  the respondents, 156 (44.6%) were aged 
between 30-39 while only 9 (2.6%) belonged to the 60 
and above age group. Two hundred (57.1%) respondents 
were females while 150 (42.9%) were males. Majority 
of  the respondents, 270(77.1%) were employed in the 
public sector while 77 (22%) were employed in the 
private sector. One hundred and sixty-four (46.9%) were 
medical doctors while 157 (44.9%) were nurses,7(2%) 
were pharmacists and 22(6.2%) belonged to the ‘’other’’ 
category (Table 1). 































Radio was the main source of  information regarding 
microbicides (30.7%) followed by Newspapers (28.5%) 
while very few respondents, 23(5.0%) obtained 
information from friends and 35.8% obtained 
information from other sources (Table 2). 
One hundred respondents (28.6%) correctly defined 
new HIV prevention strategies while majority, 185 
(52.9%) indicated that the female condom is an 
example of  new prevention technology. Three hundred 
(33.9%) of  the responses given indicated that new 
prevention technologies are drugs taken orally after 
sexual intercourse with   an    HIV infected partner 
or a partner whose sero-status is unknown to prevent 
the transmission of  HIV while 100 (11.3%) of  the 
responses indicated that microbicides were NPTs and 
a similar proportion (11.3%) also indicated that HIV 
vaccines are NPTs(Table 3).
Only 8.1% of  the respondents indicated that microbicides 
are a new group of  substances that can reduce the risk 
of  HIV and other STIs when applied topically before 
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sexual intercourse while majority, 42.7% indicated that 
microbicides are microorganisms that can destroy HIV. 
Concerning the formulation of  microbicides, 42.3% 
indicated that microbicides could be in the form of  oral 
tablets(Table 3).
Two hundred and nine (59.7%) respondents indicated 
that it would not be safe to use microbicides alongside 
other prevention methods like condoms while only 
107(30.6%) indicated that it would be safe to do so and 
9.7% indicated that they did not know.
Sixty-eight percent of  respondents indicated that 
Table 2: source of  information about microbicides











microbicides would be of  benefit to only women, 
because it is a woman-controlled method while 
95(27%) indicated that it would benefit both men and 
women. Only 36 (10.3%) respondents indicated that 
microbicides would be useful in prevention of  Mother 
to Child Transmission of  HIV while 235 (67.1%) 
indicated that it would not be useful.
Two hundred and sixty-two (75%) respondents indicated 
that they would be willing to act as community advocates 
for the microbicides campaign while only 74 (21%) 
indicated that they would not and 4% were undecided.
Table 3: knowledge and perception regarding microbicides
Knowledge Frequency Percentage
Knowledge of  what constitute new HIV prevention strategies (Only one 
response allowed)
A)New ways of  preventing the spread of  STIs including HIV which 
include microbicides  and HIV vaccines 
B)The female condom is an example of  a new prevention 
technology
C)New Prevention Technologies are meant for the developed 
countries only because of  high cost
D)New Prevention Technologies are meant for developing countries 










Which of  the following qualify to be called a New Prevention Technology? 
(Tick as many as apply)
          A)Female condoms 
          B)Microbicides
          C)HIV vaccines
          DSpermicides
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**with   an    HIV infected partner or a partner whose sero-status is unknown
What do you understand by microbicides (Tick all that apply)
Drugs taken  orally to  destroy microorganismsa) 
A new group of  substances that can reduce the risk of  HIV when b) 
applied topically before sexual intercourse
New drugs that prevent  HIV from destroying T-helper cellsc) 










































Who would benefit from using microbicides?
A) Only women, because it is a woman-controlled method
B) Both men and women
C) Only men who have sex with men (MSMs)
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Discussion
Most of  the respondents, 200(57.1%), were females. 
This may be explained by the high proportion of  
respondents who are nurses. In Nigeria, nursing is 
predominantly a female profession. Available data show 
that whereas only 20% of  physicians and dentists across 
the country are women, 97% of  nurses are women13.
The high proportion of  female participants may also 
explain why the majority of  respondents, 238(68%), 
indicated that only women would benefit from using 
microbicides since it is a woman-controlled method of  
HIV prevention. Interestingly, 235 (67.1%) respondents 
indicated that micorbicides would not be useful in 
prevention of  mother to child transmission of  HIV. This 
finding may explain why the majority of  respondents 
indicated that microbicides could not be used alongside 
other HIV prevention methods.
The number of  responses to the question on sources 
of  information regarding microbicides exceeds the 
total number of  respondents. This indicates that some 
respondents had information about microbicides from 
more than one source. This is in contrast to the findings 
of  Sow et al who found that most respondents in 
Dakar learnt about microbicides from only one source 
of  information14. The low proportion of  respondents 
who obtained information regarding microbicides from 
medical journals may be due to the high cost of  printed 
copies of  journals most of  which are beyond the reach 
of  most health care providers. The cost of  accessing the 
internet in sub-Saharan Africa is still high anh hence, 
there is low internet uptake. Thus, most health care 
providers may not have access to online journals. More 
so, some online journals require financial subscription, 
which further puts them beyond the reach of  health 
care providers in low income countries. 
The paucity of  research information on microbicides 
in local journals may further contribute to this low 
percentage. Only 9.% of  respondents obtained 
information concerning micrboicides from fellow 
health care providers. This could indicate that most 
health care providers do not know about microbicides 
so as to act as source of  information to others. This 
indicates a knowledge gap that needs to be filled 
before the microbicides come on board as health care 
commodities. 
Only 8.1% of  health care providers had  knowledge of  
what microbicides are compared to the  57% of  hospital 
managers, 40% of  pharmacists and 35% of  nurses who 
had basic knowledge about microbicides as found by 
Ramjee et al in a study among health care providers in 
South Africa10.
Majority of  respondents indicated that it would not 
be safe to use microbicides alongside other prevention 
methods like condoms. This is another knowledge gap 
that has to be addressed. From the nature of  the HIV/
AIDS pandemic, a multi-pronged prevention approach 
is necessary. 
This study found that the majority of  respondents had a 
favourable perception of  microbicides as 75% of  them 
would be willing to act as community advocates for the 
microbicides campaign. This is similar to the findings 
of  Ramjee et all which found that almost 99% of  health 
care providers  indicated their colleague’s willingness to 
recommend potential microbicides  to clients if  proven 
effective for HIV prevention7. This finding is a positive 
one and may indicate that health care providers would 
be willing to tell community members as well as their 
clients about microbicides. Such willingness is necessary 
to promote acceptance of  healthcare commodity.
There was a statistically significant association between 
professional group and willingness to act as community 
advocates for microbicides. Medical doctors were more 
willing to act as advocates than other professional groups 
p=0.0001). There was also a statistically significant 
association between sex and correct knowledge of  who 
would benefit from microbicides. Female respondents 
were more likely to have correct knowledge than 
males (p=0.0004). There was no statistically significant 
association between professional group and knowledge 
of  the formulation of  microbicides (p=0.8000).
Conclusion and recommendations
The study has identified several gaps in knowledge 
regarding microbicides that can mar its uptake as 
a health care commodity. The high number of  
respondents willing to act as community advocates for 
the microbicides campaign offers ample opportunity 
for capacity building. 
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